Cargando…

Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer

INTRODUCTION: Pretherapeutic detectable circulating tumor DNA (ctDNA) represents a promising prognostic biomarker for predicting relapse and overall survival in patients with metastatic pancreatic cancer. However, the prognostic value of ctDNA dynamics during treatment has not been studied thus far....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirchweger, Patrick, Kupferthaler, Alexander, Burghofer, Jonathan, Webersinke, Gerald, Jukic, Emina, Schwendinger, Simon, Wundsam, Helwig, Biebl, Matthias, Petzer, Andreas, Rumpold, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468369/ https://www.ncbi.nlm.nih.gov/pubmed/36110940 http://dx.doi.org/10.3389/fonc.2022.902177

Ejemplares similares

Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2023)

Data of ‘Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage’
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Prospects of conservative treatment for Clostridium septicum–associated aortitis
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Endoscopic Transmural Therapy of Pancreatic Fistulas in an Interdisciplinary Setting—A Retrospective Data Analysis
por: Meierhofer, Clara, et al.
Publicado: (2023)

Current concepts of anti-EGFR targeting in metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2022)

The Rate of Avoidable Pancreatic Resections at a High-Volume Center: An Internal Quality Control and Critical Review
por: Surci, Niccolò, et al.
Publicado: (2023)

Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment
por: Doleschal, Bernhard, et al.
Publicado: (2023)

Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis
por: Rumpold, Holger, et al.
Publicado: (2020)

Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
por: Kralik, Johanna M, et al.
Publicado: (2011)

Total resection of a giant retroperitoneal and mediastinal ganglioneuroma—case report and systematic review of the literature
por: Kirchweger, Patrick, et al.
Publicado: (2020)

Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement
por: Taghizadeh, Hossein, et al.
Publicado: (2023)

Additional Value of 2-[(18)F]FDG PET/CT Comparing to MRI in Treatment Approach of Anal Cancer Patients
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2020)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Editorial: Current innovations in GI-oncology: Where do we stand?
por: Rumpold, Holger, et al.
Publicado: (2022)

Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age
por: Niedersüß-Beke, Dora, et al.
Publicado: (2021)

Overexpression of the proneural transcription factor ASCL1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3)
por: Malli, Theodora, et al.
Publicado: (2018)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course
por: Petzer, Verena, et al.
Publicado: (2021)

Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
por: Gianni, Caterina, et al.
Publicado: (2022)

The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer
por: Luo, Kai, et al.
Publicado: (2022)

Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients
por: Muendlein, Axel, et al.
Publicado: (2022)

Surgical Excision of Duodenal/Pancreatic Metastatic Renal Cell Carcinoma
por: Espinoza, Eduardo, et al.
Publicado: (2014)

Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies
por: Malkawi, Walla, et al.
Publicado: (2023)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
por: Rice, Alistair, et al.
Publicado: (2019)

Has COVID-19 Affected Cancer Screening Programs? A Systematic Review
por: Alkatout, Ibrahim, et al.
Publicado: (2021)

Platelet-Derived Factor V Is an Important Determinant of the Metastatic Potential of Circulating Tumor Cells
por: Deng, Xin, et al.
Publicado: (2020)

Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2020)

Murine Pancreatic Acinar Cell Carcinoma Growth Kinetics Are Independent of Dietary Vitamin D Deficiency or Supplementation
por: Dooley, James, et al.
Publicado: (2017)

A Zebrafish Model of Metastatic Colonization Pinpoints Cellular Mechanisms of Circulating Tumor Cell Extravasation
por: Allen, Tyler A., et al.
Publicado: (2021)

Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations
por: Boons, Gitta, et al.
Publicado: (2018)

Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients
por: Da Col, Giacomo, et al.
Publicado: (2022)

Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation
por: Kwan, Edmond M., et al.
Publicado: (2022)

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
por: Davies, Caitlin R., et al.
Publicado: (2023)

Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer
por: Moreau, Michele, et al.
Publicado: (2019)

Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan
por: Yu, Kenneth H., et al.
Publicado: (2021)

Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
por: Pelzer, Uwe, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q6av7v1o58uqr6eisd27bpi19r